First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial

When to Start Antiretroviral Therapy in Resource-Limited Settings

(2013) Rochelle P. Walensky   ANNALS OF INTERNAL MEDICINE

Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients

(2009) Jean-François Delfraissy et al.   AIDS

Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1

(2009)   AIDS

Persistent Minority K103N Mutations among Women Exposed to Single‐Dose Nevirapine and Virologic Response to Nonnucleoside Reverse‐Transcriptase Inhibitor–Based Therapy

(2009) Ashraf Coovadia et al.   CLINICAL INFECTIOUS DISEASES

Mortality and Virologic Outcomes After Access to Antiretroviral Therapy Among a Cohort of HIV-Infected Women Who Received Single-Dose Nevirapine in Lusaka, Zambia

(2009) Louise Kuhn et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Response to Zidovudine/Didanosine-Containing Combination Antiretroviral Therapy Among HIV-1 Subtype C-Infected Adults in Botswana: Two-Year Outcomes from a Randomized Clinical Trial

(2009) Hermann Bussmann et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

First‐Line Antiretroviral Therapy in Resource‐Limited Settings: Time to Reconsider?

(2009) Rebecca Adlington et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy of Short-Course AZT Plus 3TC to Reduce Nevirapine Resistance in the Prevention of Mother-to-Child HIV Transmission: A Randomized Clinical Trial

(2009) James A. McIntyre et al.   PLOS MEDICINE